Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
Washington University School of Medicine
Washington University School of Medicine
Celgene
University of Washington
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute